Press release
Advanced Renal Cell Carcinoma Therapeutics Market Size in 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight
Advanced Renal Cell Carcinoma Market
Discover which therapies are expected to grab the Advanced Renal Cell Carcinoma Market Share @ https://www.delveinsight.com/sample-request/advanced-renal-cell-carcinoma-rcc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Advanced Renal Cell Carcinoma Market Report
• According to findings, renal cell carcinoma accounts for 90% of all kidney cancers.
• One in three people with renal cell carcinoma receive a diagnosis at the metastatic stage.
• RCC predominantly affects the male population, with men being significantly more susceptible as compared to women.
• There are several types of RCC, but 75% of patients have a type called clear cell.
• Several factors can be attributed to an increased risk of RCC, including smoking, obesity, and high blood pressure and having a family history of certain conditions, such as von Hippel-Lindau disease, a rare genetic multi-system disorder characterized by abnormal blood vessel growth.
• RCC is difficult to detect in its early stages, and >30% patients with RCC have metastatic, or advanced, cancer at the time of diagnosis, meaning the cancer cells have spread beyond the kidney to other parts of the body.
• The leading Advanced Renal Cell Carcinoma Companies such as CoImmune, Merck & Dohme, Xynomic Pharmaceuticals, NiKang Therapeutics and others.
• Promising Advanced Renal Cell Carcinoma Pipeline Therapies such as Bevacizumab, Atezolizumab, TQB2450, Anlotinib, Sunitinib, HB0025, Botensilimab, Balstilimab, Ipilimumab and others.
Stay ahead in the Advanced Renal Cell Carcinoma Therapeutics Market with DelveInsight's Strategic Report @ https://www.delveinsight.com/sample-request/advanced-renal-cell-carcinoma-rcc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Renal Cell Carcinoma Epidemiology Segmentation in the 7MM
• Advanced Renal Cell Carcinoma Incident Cases of Kidney Cancer
• Advanced Renal Cell Carcinoma Incident Cases
• Advanced Renal Cell Carcinoma Subtype-specific Incident
• Advanced Renal Cell Carcinoma Stage-specific Incident Cases
• Advanced Renal Cell Carcinoma Gender-specific Incident Cases
• Advanced Renal Cell Carcinoma Diagnosed and Treated Cases
Download the report to understand which factors are driving Advanced Renal Cell Carcinoma Epidemiology trends @ https://www.delveinsight.com/sample-request/advanced-renal-cell-carcinoma-rcc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Marketed Advanced Renal Cell Carcinoma Drugs
• KEYTRUDA (pembrolizumab): Merck
It is a highly selective humanized monoclonal IgG4 antibody directed against the PD-1 receptor on the cell surface. The drug blocks the PD-1 receptor, preventing binding and activation of PD-L1 and PD-L2. This mechanism causes the activation of T-cell mediated immune responses against tumor cells. In April 2019, the FDA approved pembrolizumab plus axitinib for the first-line treatment of patients with advanced renal cell carcinoma
• WELIREG (belzutifan): Merck
Belzutifan is an inhibitor of hypoxia-inducible factor 2 alpha (HIF-2α). HIF-2α is a transcription factor that plays a role in oxygen sensing by regulating genes that promote adaptation to hypoxia. Under normal oxygen levels, HIF-2α is targeted for ubiquitin-proteasomal degradation by VHL protein. In December 2023, the US FDA WELIREG, an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma.
Emerging Advanced Renal Cell Carcinoma Drugs
• Zanzalintinib (XL092) + Nivolumab: Exelixis/BMS
Zanzalintinib represents a next‐generation oral TKI designed to inhibit the activity of receptor tyrosine kinases associated with cancer growth and spread. These include VEGF receptors, MET, AXL, and MER, which play crucial roles in various cellular functions and pathological processes such as oncogenesis, metastasis, and tumor angiogenesis. Zanzalintinib builds upon Exelixis' extensive experience with cabozantinib, their flagship medicine, aiming to enhance key characteristics like pharmacokinetic half‐life.
• Savolitinib + Durvalumab: AstraZeneca/HUTCHMED
Savolitinib is an investigational inhibitor of the mesenchymal-epithelial transition factor, or MET receptor tyrosine kinase, an enzyme that has been shown to function abnormally in many types of solid tumors. We designed savolitinib through chemical structure modification to specifically address kidney toxicity, the primary issue that halted the development of several other selective MET inhibitors
To learn more about Advanced Renal Cell Carcinoma Treatment guidelines, visit @ https://www.delveinsight.com/sample-request/advanced-renal-cell-carcinoma-rcc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Renal Cell Carcinoma Companies
CoImmune, Merck & Dohme, Xynomic Pharmaceuticals, NiKang Therapeutics and others.
Advanced Renal Cell Carcinoma Market Outlook
Advanced Renal Cell Carcinoma companies, including Exelixis, Bristol-Myers Squibb (BMS), AstraZeneca, and HUTCHMED, are actively evaluating their lead candidates at various stages of clinical development, focusing on the treatment of advanced renal cell carcinoma. The Advanced Renal Cell Carcinoma market outlook appears promising, driven by these companies' efforts to innovate and expand the therapeutic arsenal. As these investigational therapies progress through clinical trials, they hold the potential to significantly improve patient outcomes and address unmet needs in advanced renal cell carcinoma management. The competitive landscape is poised for dynamic growth, with advancements in targeted therapies, immunotherapies, and combination treatments, ultimately aiming to enhance survival rates and quality of life for patients.
Learn more about the FDA-approved drugs for Advanced Renal Cell Carcinoma @ https://www.delveinsight.com/sample-request/advanced-renal-cell-carcinoma-rcc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Advanced Renal Cell Carcinoma Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Advanced Renal Cell Carcinoma Companies- CoImmune, Merck & Dohme, Xynomic Pharmaceuticals, NiKang Therapeutics and others.
• Advanced Renal Cell Carcinoma Pipeline Therapies- Bevacizumab, Atezolizumab, TQB2450, Anlotinib, Sunitinib, HB0025, Botensilimab, Balstilimab, Ipilimumab and others.
• Advanced Renal Cell Carcinoma Market Dynamics: Advanced Renal Cell Carcinoma Market Drivers and Barriers
• Advanced Renal Cell Carcinoma Market Access and Reimbursement, Unmet Needs and Future Perspectives
Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary of Advanced Renal Cell Carcinoma (RCC)
4. Key Events
5. Advanced Renal Cell Carcinoma Epidemiology and Market Forecast Methodology
6. Advanced Renal Cell Carcinoma Market Overview at a Glance
7. Disease Background and Overview: RCC
8. Advanced Renal Cell Carcinoma Treatment and Management
9. Epidemiology and Patient Population of RCC in Latin America and Canada
10. Advanced Renal Cell Carcinoma Patient Journey
11. Key Endpoints in Advanced RCC
12. Marketed Advanced Renal Cell Carcinoma Therapies
13. Emerging Advanced Renal Cell Carcinoma Therapies
14. Advanced RCC: the US, EU4& the UK and Japan
15. Advanced Renal Cell Carcinoma Unmet Needs
16. Advanced Renal Cell Carcinoma SWOT Analysis
17. Advanced Renal Cell Carcinoma KOL Views
18. Advanced Renal Cell Carcinoma Market Access and Reimbursement
19. Appendix
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Renal Cell Carcinoma Therapeutics Market Size in 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight here
News-ID: 4375696 • Views: …
More Releases from DelveInsight Business Research LLP
Allergic Rhinitis Therapeutic Market Size in the 7MM was ~USD 10,400 million in …
DelveInsight's "Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Allergic Rhinitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. The Allergic Rhinitis Market is an evolving segment of the global healthcare landscape, driven by the increasing Allergic Rhinitis prevalence of the disorder and the continuous…
Alagille Syndrome Treatment Market Size in the 7MM is expected to increase at a …
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Alagille Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. The Alagille Syndrome Market is an evolving segment of the global healthcare landscape, driven by the increasing Alagille Syndrome prevalence of the disorder and the continuous…
Age-Related Macular Degeneration Therapeutics Market Size in the 7MM is expected …
DelveInsight's 'Age-related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034' report deliver an in-depth understanding of the Age-related Macular Degeneration, historical and forecasted epidemiology as well as the Age-related Macular Degeneration market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Age-related Macular Degeneration Market Forecast. Click here to stay ahead in…
Progressive Multifocal Leukoencephalopathy Market Size in the 7MM is projected t …
DelveInsight's "Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Progressive Multifocal Leukoencephalopathy, historical and forecasted epidemiology, as well as the Progressive Multifocal Leukoencephalopathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. The Progressive Multifocal Leukoencephalopathy Market is an evolving segment of the global healthcare landscape, driven by the increasing Progressive Multifocal…
More Releases for Advanced
Advanced Oxidation Technologies Market Size, Share 2021, Impressive Industry Gro …
The Advanced Oxidation Technologies Market is poised to take off in upcoming years hence showing a highly positive outlook through 2020-2028, according to a recently released report. Advanced Oxidation Technologies Market report covers industry chain analysis, latest market trends & dynamics along with cost profit analysis of major key players which focuses on expansion rate, prices, competition, size, prices, and value chain analysis of those leaders in the market.
The…
Medical Ceramics Market Analysis and Industry Forecast | Advanced Ceramics Resea …
Allied Market Research published a new report, titled, “Medical Ceramics Market by Type (Aluminum Oxide, Zirconia, and Carbon, Hydroxyapatite, Glass & Bioglass, Zirconia Alumina, Bioresorbable Ceramics, and Piezo Ceramics), by Application (Surgical Instruments, Diagnostic Equipment, Orthopedic Implants, Electronic Implants, Dental Implants, Disposables, and Packaging) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five…
Skincell Advanced Reviews – Does Skincell Advanced Really Work?
People want clear, blemish-free skin! However, most people have skin tags, moles, and warts. Some causes are known, while some blemishes are caused without any reason at all. When a regular skincare regimen fails, people turn to costly surgeries and medications. Cleansing and moisturizing might not work well for all. All skin types are not the same, and toners and skincare creams seldom give long-lasting benefits.
Get Skincell Advanced From Its…
Global Advanced Oxidation Technologies Market 2019- 2025 || A-Zone Technologies, …
Synopsis of the Advanced Oxidation Technologies Market:
Latest Report on Advanced Oxidation Technologies Market deliberates the effect of various Factors influencing the market growth and drivers. Its further sheds light on market overview, key manufacturers, strategic adopted by them, size, latest trends and types, revenue, gross margin with regional analysis and forecast to 2025.
Overview of the Advanced Oxidation Technologies Market Report:
Advanced Oxidation Technologies Market report includes knowledge about the market overview…
Global Advanced Materials Market - 3M Company, DowDuPont Inc, Hexcel Corporation …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market - By Product type (Structural Material, Functional Material, Emerging Material) By End User (Building & Construction, Automotive, Aerospace, Defense, Marine, Electrical & Electronics, Healthcare, Oil & Gas and Energy, Others) & Global Region - Market Size, Trends, Share and Forecast 2018-2023” research report will include all the major trends and technologies that…
Global Advanced Materials Market: 3M Company, DowDuPont Inc, Hexcel Corporation, …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market 2017: Market Size, Trends & Opportunity Outlook – Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The…
